Skip to main content
. 2022 Jul 21;11(14):4228. doi: 10.3390/jcm11144228

Table 2.

Procedural characteristics and in-hospital complications of the patients treated with PORTICO and of the entire population and the matched population treated with ACURATE neo.

Matched Population (1:1)
PORTICO ACURATE Neo p-Value
(n = 344) (n = 344)
Procedural data
Conscious sedation 308 (89.5%) 300 (87.2%) 0.405
THV Size <0.001
  23 6 (1.7%) 49 (14.2%)
  25 93 (27.0%) 148 (43.0%)
  27 123 (35.8%) 147 (42.7%)
  29 122 (35.5%) 0 (0.0%)
Pre-dilatation 275 (79.9%) 270 (78.5%) 0.707
Post-dilatation 64 (18.6%) 110 (32.0%) <0.001
Cerebral protection 2 (0.6%) 7 (2.0%) 0.177
Procedural time (min) 52.0 (40.0–69.0) 56.0 (38.0–72.2) 0.853
Contrast (mL) 120.0 (100.0–160.0) 100.0 (80.0–130.0) <0.001
Fluoroscopy dose (Gy) 1466.5 (29.1–3463.8) 1391.0 (27.1–3635.5) 0.868
Fluoroscopy time (s) 12.5 (9.2–17.1) 10.3 (8.0–14.6) <0.001
Echocardiographic characteristics
Postprocedural mean gradient (mmHg) 8.0 (6.0–10.0) 8.0 (6.0–10.0) 0.982
Postprocedural max gradient (mmHg) 13.0 (10.0–18.0) 14.0 [11.0;18.0] 0.856
Clinical events
Major stroke/minor stroke/TIA 13 (3.8%) 12 (3.5%) 1.000
Major vascular complications 9 (4.5%) 11 (5.4%) 0.854
Life-threatening bleeding (VARC) 2 (1.0%) 4 (2.0%) 0.685
Renal failure (AKIN 2/3) 12 (3.5%) 13 (3.8%) 0.994
Coronary artery obstruction with PCI 0 (0.0%) 3 (1.5%) 0.248
Myocardial infarction 6 (3.0%) 8 (3.9%) 0.815
Permanent pacemaker implantation 1 52 (18.7%) 28 (9.5%) 0.002
Days in hospital 7.0 (6.0–10.0) 7.5 (6.0–11.0) 0.965
Days in the intensive care unit 2.0 (1.0–3.0) 2.0 (1.0–3.0) 0.825
In-hospital mortality 10 (2.9%) 10 (2.9%) 1.000

Values are the mean ± SD, n (%) or median (interquartile range). 1 Excluding patients with pacemakers at the baseline (n = 115 in the matched population). VARC = Valve Academic Research Consortium, AKIN = Acute Kidney Injury Network, TIA = transitory ischemic attack.